Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma (HGG)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Very early researchLooking for participantsNCT05553041
What this trial is testing

18F-Fluciclovine PET-MRI in High-grade Glioma

Who this might be right for
GliomaHigh Grade GliomaGlioma, Malignant+2 more
Children's Hospital of Philadelphia 30
Testing effectiveness (Phase 2)Study completedNCT02684058
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+19 more
Novartis Pharmaceuticals 151
Early research (Phase 1)Ended earlyNCT01902771
What this trial is testing

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Who this might be right for
GliomaBrain CancerBrain Tumor+2 more
Edward Ziga 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567469
What this trial is testing

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

Who this might be right for
High-Grade Glioma (HGG)Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT03257631
What this trial is testing

Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Who this might be right for
Central Nervous System NeoplasmsMedulloblastoma
Celgene 53
Testing effectiveness (Phase 2)Study completedNCT01602588
What this trial is testing

A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)

Who this might be right for
Glioblastoma
University College, London 54
Testing effectiveness (Phase 2)Study completedNCT00717197
What this trial is testing

Study of Capecitabine to Treat Recurrent High Grade Gliomas

Who this might be right for
Malignant Glioma
University of Florida 30
Early research (Phase 1)Looking for participantsNCT07664176
What this trial is testing

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

Who this might be right for
Diffuse Midline Glioma or Diffuse Intrinsic Pontine GliomaHigh Grade GliomasMedulloblastoma Recurrent+3 more
Children's National Research Institute 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07694089
What this trial is testing

Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas

Who this might be right for
High-grade Gliomas (HGG)
Akshitkumar MIstry 80
Very early researchLooking for participantsNCT07210632
What this trial is testing

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Who this might be right for
Brain CancerHGGGlioma+4 more
Eben Rosenthal 38
Testing effectiveness (Phase 2)Looking for participantsNCT05843253
What this trial is testing

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic Astrocytoma+7 more
Nationwide Children's Hospital 120
Early research (Phase 1)Not Yet RecruitingNCT07455045
What this trial is testing

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Who this might be right for
High Grade Glioma (III or IV)Diffuse Midline Glioma (DMG)Glioblastoma (GBM)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 40
Not applicableUnknownNCT02239952
What this trial is testing

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Who this might be right for
CancerHigh-grade Glioma
Amsterdam UMC, location VUmc 15
Not applicableNot Yet RecruitingNCT07725640
What this trial is testing

Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma

Who this might be right for
GliomaHigh-Grade Glioma (HGG)Surgical Resection
Batea Oncology 15
Early research (Phase 1)Looking for participantsNCT07061626
What this trial is testing

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

Who this might be right for
EpendymomaHigh Grade Gliomas
Cerenome 56
Early research (Phase 1)Study completedNCT01985256
What this trial is testing

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Tocagen Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT06018363
What this trial is testing

Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection

Who this might be right for
Brain GliomasHigh-Grade GliomasGBM
Dushu Lake Hospital Affiliated to Soochow University 25
Early research (Phase 1)WithdrawnNCT02598011
What this trial is testing

The Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care

Who this might be right for
Newly Diagnosed High Grade Glioma (HGG)
Tocagen Inc.